Welcome to TRiCares.
We are a medical device company, devoted to developing a catheter-based valve replacement system for minimal invasive treatment of tricuspid valve regurgitation.
Please send all inquiries for information and questions to:
N E W S : Press Release, June 2018
27 Avenue de l'Opéra | 75001 Paris | France
Heisenbergbogen 2 | 85609 Aschheim / Munich | Germany
President and CEO:
Helmut J. Straubinger
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 830574